ATOSSA THERAPEUTICS INC (ATOS)

US04962H5063 - Common Stock

1.55  +0.02 (+1.31%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
31.38M27.69M20.52M14.61M17.27M
Research and Development
17.33M15.08M9.21M6.61M6.65M
Selling, General, and Administrative Expenses
14.04M12.61M11.31M8.00M10.62M
Operating Income
-31.38M-27.69M-20.52M-14.61M-17.27M
Interest Income/Expense
4.34M760.00KN/AN/AN/A
Other Income/Expense
-70.00K-20.00K-90.00K-3.22M30.00K
Non Recurring Items
-2.99MN/AN/AN/AN/A
Income Before Taxes
-30.09M-26.96M-20.61M-17.83M-17.24M
Income Tax
0.000.000.000.000.00
Net Income
-30.09M-26.96M-20.61M-22.33M-17.24M
EBITDA
-31.35M-27.68M-20.50M-14.56M-17.22M
 
Per Share Data
EPS Diluted Total Ops
-0.24-0.21-0.18-1.97-2.03
Non GAAP EPS
-0.27-0.21-0.18-1.97N/A
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts